Item(s): 0
Total: [ 0.00 GBP | 0.0000000 BTC ]
CLICK HERE TO BUY
Erlotinib 150mg is a prescription medication used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It belongs to a class of drugs called tyrosine kinase inhibitors.
Uses:
- Non-Small Cell Lung Cancer (NSCLC): Erlotinib is used in patients with advanced or metastatic NSCLC whose tumors have specific mutations in the epidermal growth factor receptor (EGFR) gene.
- Pancreatic Cancer: Erlotinib is used in combination with gemcitabine to treat locally advanced, unresectable, or metastatic pancreatic cancer.
Dosage:
The recommended dose of erlotinib is 150 mg taken orally once daily at least 1 hour before or 2 hours after a meal. The dosage may be adjusted based on individual patient requirements and the presence of side effects.
Side effects:
Erlotinib can cause some side effects, which can be mild or severe, and may include:
- Rash
- Diarrhea
- Fatigue
- Loss of appetite
- Nausea and vomiting
- Infections
- Difficulty breathing
- Severe skin reactions
- Eye irritation and inflammation
- Elevated liver enzyme levels
Precautions:
- Inform your doctor if you have a history of liver disease, kidney disease, or any other medical condition before taking erlotinib.
- Tell your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
- Avoid drinking grapefruit juice while taking erlotinib.
- Erlotinib can cause dizziness and blurred vision. Do not drive or operate heavy machinery until you know how the medication affects you.
- Contact your doctor if you experience any severe side effects, such as difficulty breathing or severe skin reactions.
Note: This is general information only and is not intended to replace professional medical advice. Always consult your doctor or healthcare provider for personalized medical advice.
For similar products for Cancer medication, Click here
This item is not available to ship to Canada and EU Countries.